112 related articles for article (PubMed ID: 23523643)
21. An observational study examining the effect of comorbidity on the rates of persistence and adherence to newly initiated oral anti-hyperglycaemic agents.
O'Shea MP; Teeling M; Bennett K
Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1336-44. PubMed ID: 24142802
[TBL] [Abstract][Full Text] [Related]
22. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
[TBL] [Abstract][Full Text] [Related]
23. Does antidepressant medication use affect persistence with diabetes medicines?
Caughey GE; Preiss AK; Vitry AI; Gilbert AL; Ryan P; Shakib S; Esterman A; McDermott RA; Roughead EE
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):615-22. PubMed ID: 23447430
[TBL] [Abstract][Full Text] [Related]
24. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients.
Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC
Med Care; 2008 Nov; 46(11):1125-33. PubMed ID: 18953222
[TBL] [Abstract][Full Text] [Related]
25. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
26. Venue of receiving diabetes self-management education and training and its impact on oral diabetic medication adherence.
Wu J; Davis-Ajami ML; Noxon V; Lu ZK
Prim Care Diabetes; 2017 Apr; 11(2):162-170. PubMed ID: 27840086
[TBL] [Abstract][Full Text] [Related]
27. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy.
Barner JC
Clin Ther; 2011 Sep; 33(9):1281-8. PubMed ID: 21840054
[TBL] [Abstract][Full Text] [Related]
28. Adherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naïve patients with type 2 diabetes.
Buysman E; Conner C; Aagren M; Bouchard J; Liu F
Curr Med Res Opin; 2011 Sep; 27(9):1709-17. PubMed ID: 21740289
[TBL] [Abstract][Full Text] [Related]
29. Persistence and compliance of deferoxamine versus deferasirox in Medicaid patients with sickle-cell disease.
Jordan LB; Vekeman F; Sengupta A; Corral M; Guo A; Duh MS
J Clin Pharm Ther; 2012 Apr; 37(2):173-81. PubMed ID: 21592159
[TBL] [Abstract][Full Text] [Related]
30. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.
Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791
[TBL] [Abstract][Full Text] [Related]
31. Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain.
Wu N; Chen S; Boulanger L; Fraser K; Bledsoe SL; Zhao Y
J Med Econ; 2009 Sep; 12(3):192-202. PubMed ID: 19705975
[TBL] [Abstract][Full Text] [Related]
32. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents.
Kalsekar ID; Madhavan SS; Amonkar MM; Makela EH; Scott VG; Douglas SM; Elswick BL
Ann Pharmacother; 2006 Apr; 40(4):605-11. PubMed ID: 16551768
[TBL] [Abstract][Full Text] [Related]
33. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
[TBL] [Abstract][Full Text] [Related]
34. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
[TBL] [Abstract][Full Text] [Related]
35. The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment.
Maggi S; Noale M; Pilotto A; Tiengo A; Cavallo Perin P; Crepaldi G;
Diabetes Metab; 2013 May; 39(3):236-43. PubMed ID: 23522733
[TBL] [Abstract][Full Text] [Related]
36. Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension.
An J; Nichol MB
Med Care; 2013 Oct; 51(10):879-87. PubMed ID: 23929398
[TBL] [Abstract][Full Text] [Related]
37. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
Vanderpoel DR; Hussein MA; Watson-Heidari T; Perry A
Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770
[TBL] [Abstract][Full Text] [Related]
38. Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life.
Pollack MF; Purayidathil FW; Bolge SC; Williams SA
Diabetes Res Clin Pract; 2010 Feb; 87(2):204-10. PubMed ID: 20036433
[TBL] [Abstract][Full Text] [Related]
39. Statin use in Type 2 diabetes mellitus is associated with a delay in starting insulin.
Yee A; Majumdar SR; Simpson SH; McAlister FA; Tsuyuki RT; Johnson JA
Diabet Med; 2004 Sep; 21(9):962-7. PubMed ID: 15317599
[TBL] [Abstract][Full Text] [Related]
40. Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database.
Rascati KL; Richards KM; Lopez D; Cheng LI; Wilson JP
Clin Ther; 2011 Dec; 33(12):2016-20. PubMed ID: 22101160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]